Cargando…
Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice
AIMS/HYPOTHESIS: Sphingolipid metabolism regulates beta cell biology and inflammation and is abnormal at the onset of type 1 diabetes. Fenofibrate, a regulator of sphingolipid metabolism, is known to prevent diabetes in NOD mice. Here, we aimed to investigate the effects of fenofibrate on the pancre...
Autores principales: | Holm, Laurits J., Haupt-Jorgensen, Martin, Giacobini, Jano D., Hasselby, Jane P., Bilgin, Mesut, Buschard, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861358/ https://www.ncbi.nlm.nih.gov/pubmed/31410530 http://dx.doi.org/10.1007/s00125-019-04973-z |
Ejemplares similares
-
L-serine supplementation lowers diabetes incidence and improves blood glucose homeostasis in NOD mice
por: Holm, Laurits J., et al.
Publicado: (2018) -
Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment
por: Buschard, Karsten, et al.
Publicado: (2020) -
Possible Prevention of Diabetes with a Gluten-Free Diet
por: Haupt-Jorgensen, Martin, et al.
Publicado: (2018) -
Abnormal islet sphingolipid metabolism in type 1 diabetes
por: Holm, Laurits J., et al.
Publicado: (2018) -
PPARs and the Development of Type 1 Diabetes
por: Holm, Laurits J., et al.
Publicado: (2020)